Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Obstetricia y Ginecología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Completado
Fase 3
ClinicalTrials.gov
A Phase 3 Randomized, Placebo-Controlled Trial of Carboplatin and Paclitaxel With or Without the PARP Inhibitor Veliparib (ABT-888) in HER2-Negative Metastatic or Locally Advanced Unresectable BRCA-Associated Breast Cancer
INTERVENTIONAL
Inicio: 8 de abr de 2014
ID: NCT02163694
Desconocido
ClinicalTrials.gov
Evaluation of Response to Two Schedules of Capecitabine in Patients With Metastatic Breast Cancer
INTERVENTIONAL
Inicio: 1 de ago de 2013
ID: NCT02028494
Completado
Fase 3
ClinicalTrials.gov
An Open-Label Multicenter Randomized Phase 3 Study Comparing the Combination of DOXIL/CAELYX and YONDELIS With DOXIL/CAELYX Alone in Subjects With Advanced Relapsed Ovarian Cancer
INTERVENTIONAL
Inicio: 1 de abr de 2005
ID: NCT00113607
Completado
Fase 3
ClinicalTrials.gov
A Randomized Phase 3 Study Of Docetaxel In Combination With Sunitinib Versus Docetaxel In The First-Line Treatment Of Advanced Breast Cancer Patients
INTERVENTIONAL
Inicio: 1 de feb de 2007
ID: NCT00393939
Reclutando
Fase 3
ClinicalTrials.gov
A Multicenter Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Zigakibart in Adults With Primary IgA Nephropathy.
INTERVENTIONAL
Inicio: 28 de jul de 2025
ID: NCT06858319
Completado
Fase 3
ClinicalTrials.gov
Elacestrant Monotherapy vs. Standard of Care for the Treatment of Patients With ER+/HER2- Advanced Breast Cancer Following CDK4/6 Inhibitor Therapy: A Phase 3 Randomized, Open-label, Active-controlled, Multicenter Trial
INTERVENTIONAL
Inicio: 10 de may de 2019
ID: NCT03778931
Completado
ClinicalTrials.gov
A Phase III Randomized Clinical Trial of Laparoscopic or Robotic Radical Hysterectomy Versus Abdominal Radical Hysterectomy in Patients With Early Stage Cervical Cancer
INTERVENTIONAL
Inicio: 1 de ene de 2008
ID: NCT00614211
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Multicenter, Double-Blind, Placebo-Controlled, 2-Arm, Phase III Study of Oral GW572016 in Combination With Paclitaxel in Subjects Previously Untreated or Advanced or Metastatic Breast Cancer
INTERVENTIONAL
Inicio: 1 de ene de 2004
ID: NCT00075270
Completado
Fase 3
ClinicalTrials.gov
A Phase III Randomized Double-blind, Placebo Controlled Study of Alpelisib in Combination With Fulvestrant for Men and Postmenopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast Cancer Which Progressed on or After Aromatase Inhibitor Treatment
INTERVENTIONAL
Inicio: 23 de jul de 2015
ID: NCT02437318
Completado
Fase 3
ClinicalTrials.gov
A Phase IIIB, Multinational, Multicenter, Randomized, Open-Label Study to Evaluate Patient Preference for Home Administration of Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Administration in Participants With Early or Locally Advanced/Inflammatory HER2-Positive Breast Cancer
INTERVENTIONAL
Inicio: 5 de jul de 2022
ID: NCT05415215
Reclutando
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Open-label Study Comparing Efficacy and Safety of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as a Monotherapy and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With Previously Untreated Locally Recurrent Unresectable or Metastatic Triple-Negative Breast Cancer Expressing PD-L1 at CPS Less Than 10 (TroFuse-011)
INTERVENTIONAL
Inicio: 16 de mar de 2025
ID: NCT06841354
Completado
Fase 3
ClinicalTrials.gov
Phase III Trial of IV Vinflunine Versus an Alkylating Agent in Patients With Metastatic Breast Cancer Previously Treated With or Resistant to an Anthracycline, a Taxane, an Antimetabolite, and a Vinca-alkaloid (Study L00070 IN 308 B0)
INTERVENTIONAL
Inicio: 1 de jul de 2009
ID: NCT01091168
Reclutando
Fase 3
ClinicalTrials.gov
A Phase III Randomized, Open-Label Study Evaluating Efficacy and Safety of Giredestrant Compared With Fulvestrant, Both Combined With a CDK4/6 Inhibitor, in Patients With Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer With Resistance to Prior Adjuvant Endocrine Therapy
INTERVENTIONAL
Inicio: 11 de dic de 2023
ID: NCT06065748
Desconocido
Fase 2
ClinicalTrials.gov
Docetaxel (DTX) - Ifosfamide (IFX) As First Line Chemotherapy In Metastatic Breast Cancer
INTERVENTIONAL
Inicio: 1 de mar de 2001
ID: NCT00026078
Completado
Fase 3
ClinicalTrials.gov
The "EMBRACE" Trial: Eisai Metastatic Breast Cancer Study Assessing Physician's Choice Versus E7389. A Phase III Open-Label, Randomized, Parallel, Two-arm, Multi-center Study of E7389 Versus "Treatment of Physician's Choice" in Patients With Locally Recurrent, Metastatic Breast Cancer, Previously Treated With At Least Two and a Maximum of Five Prior Chemotherapy Regimens, Including an Anthracycline and a Taxane
INTERVENTIONAL
Inicio: 1 de nov de 2006
ID: NCT00388726
Desconocido
Fase 3
ClinicalTrials.gov
A Phase III Randomized, Controlled Trial of Myocet, Trastuzumab and Paclitaxel Versus Trastuzumab and Paclitaxel for First-Line Therapy of Metastatic Breast Cancer
INTERVENTIONAL
Inicio: 1 de ene de 2006
ID: NCT00294996
Completado
Fase 4
ClinicalTrials.gov
An Open Label, Multicentre Study of Nexium (Esomeprazole) 40 mg Once Daily in Subjects With Symptoms of Gastroesophageal Reflux Disease (GORD) After Treatment With a Full Dose of Proton Pump Inhibitor (PPI)
INTERVENTIONAL
Inicio: 1 de nov de 2007
ID: NCT00734097
Terminado
Fase 2
ClinicalTrials.gov
A Double-Blind, Randomized, Phase 2 Trial of Capecitabine Plus Enzastaurin Versus Capecitabine Plus Placebo in Patients With Metastatic or Recurrent Breast Cancer Previously Treated With an Anthracycline and a Taxane
INTERVENTIONAL
Inicio: 1 de mar de 2007
ID: NCT00437294
Reclutando
ClinicalTrials.gov
Trauma-informed Obstetric Care for Perinatal Health in Women With Histories of Childhood Abuse: a Pilot Randomized Clinical Trial
INTERVENTIONAL
Inicio: 23 de may de 2025
ID: NCT07195058
Completado
ClinicalTrials.gov
A Study to Determine Biopsy Rate in Participants With a First Relapse of Breast Cancer
OBSERVATIONAL
Inicio: 1 de jun de 2016
ID: NCT02761616
Anterior
1
...
7
8
9
...
434
Siguiente
Filtros